Tiazofurin
Term · Oncology and biomedicine · MLC-T-ONC-008706
An anticancer drug being studied to stop cell growth.
A synthetic nucleoside analogue with antineoplastic activity. Tiazofurin (TR) is anabolized intracellularly to an analogue of NAD, tiazole-4-carboxamide adenine dinucleotide (TAD), a potent inhibitor of IMP dehydrogenase (IMPDH); IMPDH is the rate-limiting enzyme for de novo purine synthesis. Inhibition of IMPDH results in reduced levels of guanylates, resulting in the inhibition tumor cell growth in vitro and in vivo.
| Identifier | MLC-T-ONC-008706 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | TCAR |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-008706",
"term": "Tiazofurin",
"field": "Oncology and biomedicine",
"definitions": [
"An anticancer drug being studied to stop cell growth.",
"A synthetic nucleoside analogue with antineoplastic activity. Tiazofurin (TR) is anabolized intracellularly to an analogue of NAD, tiazole-4-carboxamide adenine dinucleotide (TAD), a potent inhibitor of IMP dehydrogenase (IMPDH); IMPDH is the rate-limiting enzyme for de novo purine synthesis. Inhibition of IMPDH results in reduced levels of guanylates, resulting in the inhibition tumor cell growth in vitro and in vivo."
],
"abbreviation": "TCAR",
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/tiazofurin/"
}
Record 16,350 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.